Skip to main content
. 2020 Nov 17;159(3):1256–1264. doi: 10.1016/j.chest.2020.10.081

Figure 1.

Figure 1

Competing risk plot depicting the cumulative incidence of MPE recurrence at 100 d by actionable mutation status with death as a competing risk (subdistribution hazard ratio, 1.487; 95% CI, 1.07-2.07; P = .018). MPE = malignant pleural effusion.